IMC Could Become Latest To Exit Cannabis Space, Jazz Pharma Reports $900m In 2023 Epidyolex Sales, & More From DanCann Pharma
IM Cannabis IM Cannabis has become the latest major Israeli cannabis company to announce potential plans to depart the industry